Altiva Management Inc. is 10% Owner at PROGENICS PHARMACEUTICALS INC (PGNX). They have made 1 open-market trade across 1 company since 2019, most recently 2019-09-09.
CIK 0001772491
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $719K since 2019, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PGNX | 8,011,733 | $32.8M |
Shares reported on the most recent Form 4, priced at the 2019-09-11 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PGNX | BUY | 2019-09-09 | 2019-09-11 | $4.99 | $719K | -2.3% | -6.5% | -10.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.